Education
About Us
Working with TipRanks
Follow Us
Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
IART Stock Chart & Stats
$13.12
-$0.23(-1.04%)
At close: 4:00 PM EST
$13.12
-$0.23(-1.04%)
Day’s Range― - ―
52-Week Range$10.87 - $27.13
Previous CloseN/A
Volume73.30K
Average Volume (3M)1.19M
Market Cap
$1.02B
Enterprise Value$2.84B
Total Cash (Recent Filing)$267.88M
Total Debt (Recent Filing)$213.51M
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Feb 25, 2026EPS Estimate
0.8Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.54
Shares Outstanding77,892,110
10 Day Avg. Volume945,487
30 Day Avg. Volume1,185,954
Financial Highlights & Ratios
PEG Ratio2.28
Price to Book (P/B)1.13
Price to Sales (P/S)1.08
P/FCF Ratio69.96
Enterprise Value/Market Cap2.78
Enterprise Value/Revenue1.73
Enterprise Value/Gross Profit3.23
Enterprise Value/Ebitda-9.06
Forecast
1Y Price Target
$12.33Price Target Upside-6.02% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering6
EPS Forecast (FY)2.2
Revenue Forecast (FY)$1.63B
Bulls Say, Bears Say
Bulls Say
Leadership And TurnaroundThere is potential for a multi-year turnaround under new leadership if regulatory issues are managed effectively.
Revenue PerformanceTotal revenues of $383 million were slightly above consensus of $381 million and within the midpoint of guidance.
Bears Say
Guidance And EstimatesThe company's estimates continue to have a downward bias, making it challenging to predict future performance accurately.
Operational ChallengesThe company is facing ongoing issues with shipholds and capacity, which are affecting its overall performance.
Regulatory And ComplianceThere is a cautious outlook on the company's shares due to concerns about structural damage from extended shipholds and compliance issues.
Integra Lifesciences News
IART FAQ
What was Integra Lifesciences Holdings Corp.’s price range in the past 12 months?
Integra Lifesciences Holdings Corp. lowest stock price was $10.87 and its highest was $27.13 in the past 12 months.
What is Integra Lifesciences Holdings Corp.’s market cap?
Integra Lifesciences Holdings Corp.’s market cap is $1.02B.
When is Integra Lifesciences Holdings Corp.’s upcoming earnings report date?
Integra Lifesciences Holdings Corp.’s upcoming earnings report date is Feb 25, 2026 which is in 85 days.
How were Integra Lifesciences Holdings Corp.’s earnings last quarter?
Integra Lifesciences Holdings Corp. released its earnings results on Oct 30, 2025. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.434 by $0.106.
Is Integra Lifesciences Holdings Corp. overvalued?
According to Wall Street analysts Integra Lifesciences Holdings Corp.’s price is currently Overvalued.
Does Integra Lifesciences Holdings Corp. pay dividends?
Integra Lifesciences Holdings Corp. does not currently pay dividends.
What is Integra Lifesciences Holdings Corp.’s EPS estimate?
Integra Lifesciences Holdings Corp.’s EPS estimate is 0.8.
How many shares outstanding does Integra Lifesciences Holdings Corp. have?
Integra Lifesciences Holdings Corp. has 77,892,110 shares outstanding.
What happened to Integra Lifesciences Holdings Corp.’s price movement after its last earnings report?
Integra Lifesciences Holdings Corp. reported an EPS of $0.54 in its last earnings report, beating expectations of $0.434. Following the earnings report the stock price went down -23.461%.
Which hedge fund is a major shareholder of Integra Lifesciences Holdings Corp.?
Currently, no hedge funds are holding shares in IART
Integra Lifesciences Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$12.33 (-6.02% Downside)
$12.33 (-6.02% Downside)
Blogger Sentiment
Bullish
IART Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 139.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $102.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.53%
12-Months-Change
Fundamentals
Return on Equity
-38.71%
Trailing 12-Months
Asset Growth
-10.31%
Trailing 12-Months
Company Description
Integra Lifesciences Holdings Corp.
Integra LifeSciences Holdings Corporation (IART) is a global leader in the development of innovative medical devices and regenerative technologies, primarily focused on neurosurgery, orthopedics, and reconstructive surgery. The company offers a wide range of products including surgical instruments, wound care solutions, and biologics, aimed at improving patient outcomes and enhancing surgical procedures. With a commitment to advancing healthcare, Integra serves hospitals and healthcare providers worldwide.
IART Company Deck
IART Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong operational efficiency and strategic advancements like the early relaunch of key products. However, these positives were counterbalanced by supply chain disruptions, challenges in the ENT and Private Label segments, and a lowered full-year guidance, reflecting a mixed performance.View all IART earnings summariesIART Stock 12 Month Forecast
Average Price Target
$12.33
▼(-6.02% Downside)
Technical Analysis
Ownership Overview
3.33% Insiders
29.70% Mutual Funds
30.86% Other Institutional Investors
9.63% Public Companies and
Individual Investors